Skip to main content

. 1979 Apr 28;1(6171):1120–1121. doi: 10.1136/bmj.1.6171.1120-a

Controlled trial of cyclophosphamide in active chronic hepatitis.

I T Gilmore, R E Cowan, A T Axon, R P Thompson, M J Wheeler

PMCID: PMC1598742 PMID: 376043

1120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Fairley K. F., Barrie J. U., Johnson W. Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet. 1972 Mar 11;1(7750):568–569. doi: 10.1016/s0140-6736(72)90358-3. [DOI] [PubMed] [Google Scholar]
Pengelly C. D., Jennings R. C. Remission of active chronic hepatitis after treatment with cyclophosphamide and prednisolone. Report of four cases. Practitioner. 1975 Feb;214(1280):233–242. [PubMed] [Google Scholar]
Soloway R. D., Summerskill W. H., Baggenstoss A. H., Geall M. G., Gitnićk G. L., Elveback I. R., Schoenfield L. J. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed] [Google Scholar]
Summerskill W. H., Korman M. G., Ammon H. V., Baggenstoss A. H. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 1975 Nov;16(11):876–883. doi: 10.1136/gut.16.11.876. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES